Thomas Haughey, Director at ANI PHARMACEUTICALS INC (ANIP), bought 2,500 shares at $39.38 ($98K) on 2021-12-06, disclosed to the SEC on 2021-12-07.
Open-market purchase of $98k ANIP by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| ANIP | BUY | 2020-03-05 | $226K | — | Filing → |
| ANIP | BUY | 2019-05-15 | $173K | — | Filing → |
| PRX | SELL | 2011-05-11 | $953K | — | Filing → |